| ATP | adenosine triphosphate |
| BDNF | brain-derived neurotrophic factor |
| bFGF | basic fibroblast growth factor |
| CCL5/RANTES | CC-chemokine ligand 5 |
| CD40L | CD40 ligand |
| CFU | colony-forming units |
| cMYC | myc proto-oncogene protein |
| DENV | dengue virus |
| DNA | deoxyribonucleic acid |
| ECFCs | endothelial colony-forming progenitor cells |
| EGF | epidermal growth factor |
| EIA/ECLIA | enzyme- or electro-chemiluminiscence immunoassays |
| ELISA | enzyme-linked immunosorbent assay |
| EMA | European Medicine Agency |
| EU | endotoxin unit |
| FBS | fetal bovine serum |
| FDA | U.S. Food and Drug Administration |
| GF | growth factor |
| GMP | good manufacturing practice |
| HAV | hepatitis A virus |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| HEV | hepatitis E virus |
| HGF | hepatocyte growth factor |
| HIV-1/2 | human immunodeficiency virus type 1 or type 2 |
| HPL | human platelet lysate |
| IAT | indirect antiglobulin test |
| ICAM-1 | intercellular adhesion molecule 1 |
| IGF-1 | insulin-like growth factor 1 |
| IU | international units |
| KLF4 | Kruppel-like factor 4 |
| LAL | limulus amebocyte lysate |
| MPCs | myoprogenitor cells |
| MSCs | mesenchymal stromal cells |
| NAT | nucleic acid amplification technology |
| PB19 | parvovirus B19 |
| PCR | polymerase chain reaction |
| PCR-SSP | polymerase chain reaction-single specific primer |
| PDGF | platelet-derived growth factor |
| PR | pathogen reduction |
| PRP | platelet rich plasma |
| rh | recombinant human |
| RNA | ribonucleic acid |
| S/D | solvent/detergent |
| SOX2 | sex-determining region Y (SRY)- box 2 |
| SPC | statistical process control |
| TGF-β | transforming growth factor β |
| U.S. | United States |
| USP | U.S. Pharmacopeia |
| UV | ultraviolet |
| VCAM-1 | vascular cell adhesion molecule-1 |
| VEGF | vascular endothelial growth factor |
| WNV | West Nile virus |
| ZIKV | Zika virus |